Early Predictors of 9‐Year Disability in Pediatric Multiple Sclerosis-Reference-Cited by-同舟云学术

Early Predictors of 9‐Year Disability in Pediatric Multiple Sclerosis

Published:2021-02-27 Issue:5 Volume:89 Page:1011-1022
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Annals of Neurology

Author:

De Meo Ermelinda¹²,Bonacchi Raffaello¹³,Moiola Lucia³,Colombo Bruno³,Sangalli Francesca³,Zanetta Chiara³,Amato Maria Pia⁴⁵,Martinelli Vittorio³,Rocca Maria Assunta¹²³^ORCID,Filippi Massimo¹²³⁶⁷^ORCID

Affiliation:

1. Neuroimaging Research Unit, Division of Neuroscience IRCCS San Raffaele Scientific Institute Milan Italy

2. Vita‐Salute San Raffaele University Milan Italy

3. Neurology Unit IRCCS San Raffaele Scientific Institute Milan Italy

4. Department NEUROFARBA, Section of Neurosciences University of Florence Florence Italy

5. IRCCS Fondazione Don Carlo Gnocchi Florence Italy

6. Neurorehabilitation Unit IRCCS San Raffaele Scientific Institute Milan Italy

7. Neurophysiology Service IRCCS San Raffaele Scientific Institute Milan Italy

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.26052

Reference56 articles.

1. Natural History of Multiple Sclerosis with Childhood Onset

2. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood

3. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions

4. Prognostic Factors for Early Severity in a Childhood Multiple Sclerosis Cohort

5. Prognostic indicators in pediatric clinically isolated syndrome

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High NEDA and No PIRA in Natalizumab-Treated Patients With Pediatric-Onset Multiple Sclerosis;Neurology Neuroimmunology & Neuroinflammation;2024-09

2. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries;The Lancet Child & Adolescent Health;2024-05

3. Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis;JAMA Neurology;2024-03-01

4. Pediatric multiple sclerosis and acute disseminated encephalomyelitis;The Rose and Mackay Textbook of Autoimmune Diseases;2024

5. Disease modifying treatment for pediatric onset multiple sclerosis: Ethical considerations and strategies to navigate parental refusal;Multiple Sclerosis and Related Disorders;2023-11